Definitive Healthcare Corp (DH)vsHinge Health, Inc. (HNGE)
DH
Definitive Healthcare Corp
$1.26
-3.82%
HEALTHCARE · Cap: $140.38M
HNGE
Hinge Health, Inc.
$121.29
+5.11%
HEALTHCARE · Cap: $9.94B
Smart Verdict
WallStSmart Research — data-driven comparison
Hinge Health, Inc. generates 252% more annual revenue ($800.82M vs $227.31M). HNGE leads profitability with a 21.0% profit margin vs -69.2%. HNGE earns a higher WallStSmart Score of 56/100 (C).
DH
Hold37
out of 100
Grade: F
HNGE
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+74.6%
Fair Value
$6.66
Current Price
$1.26
$5.40 discount
Intrinsic value data unavailable for HNGE.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Revenue surging 52.4% year-over-year
Keeps 21 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Strong operational efficiency at 22.5%
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -116.5% — below average capital efficiency
Revenue declined 9.0%
Premium valuation, high expectations priced in
Weak financial health signals
Trading at 32.8x book value
ROE of -197.2% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : DH
The strongest argument for DH centers on Price/Book, Debt/Equity.
Bull Case : HNGE
The strongest argument for HNGE centers on Revenue Growth, Profit Margin, Debt/Equity. Profitability is solid with margins at 21.0% and operating margin at 22.5%. Revenue growth of 52.4% demonstrates continued momentum.
Bear Case : DH
The primary concerns for DH are EPS Growth, Market Cap, Return on Equity.
Bear Case : HNGE
The primary concerns for HNGE are P/E Ratio, Piotroski F-Score, Price/Book.
Key Dynamics to Monitor
DH profiles as a turnaround stock while HNGE is a growth play — different risk/reward profiles.
HNGE is growing revenue faster at 52.4% — sustainability is the question.
HNGE generates stronger free cash flow (113M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
HNGE scores higher overall (56/100 vs 37/100), backed by strong 21.0% margins and 52.4% revenue growth. DH offers better value entry with a 74.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Definitive Healthcare Corp
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Definitive Healthcare Corp (DH) is a leading provider of comprehensive data and analytics solutions designed specifically for the healthcare industry, catering to a diverse clientele that includes pharmaceutical companies, payers, and healthcare providers. By harnessing extensive datasets and cutting-edge real-time analytics, Definitive Healthcare enhances operational efficiencies and delivers critical strategic insights, ultimately improving patient outcomes. With a strong commitment to innovation, the company is well-positioned to capitalize on the growing demand for sophisticated healthcare analytics, thereby establishing itself as a pivotal player in the transformation of healthcare delivery.
Visit Website →Hinge Health, Inc.
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?